Clinical trial
Rosiglitazone and Exercise in Patients With Type 2 Diabetes Mellitus
NCT00306176 · Aristotle University Of Thessaloniki, Other · Completed
Key facts
| NCT number | NCT00306176 |
|---|---|
| Title | Rosiglitazone and Exercise in Patients With Type 2 Diabetes Mellitus |
| Official title | Rosiglitazone and Exercise in Patients With Type 2 Diabetes Mellitus |
| Lead sponsor | Aristotle University Of Thessaloniki, Other |
| Collaborators | University of Athens |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Type II Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Rosiglitazone |
| Enrollment | 100 |
| Start date | Jan 1, 2005 |
| Completion | Oct 1, 2006 |
| First posted | Mar 23, 2006 |
| Last update posted | Apr 4, 2007 |
| Countries | Greece |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: